MEDI 281-Substrate-mimetic inhibitors of Akt as potential anti-cancer therapeutics

MEDI 281-Substrate-mimetic inhibitors of Akt as potential anti-cancer therapeutics

Detalles Bibliográficos
Autores principales:	Kayser, K, Glenn, M, Yang, L, Cheng, J, Hamilton, A
Formato:	Journal article
Publicado:	2006

Ejemplares similares

Non-peptidic substrate-mimetic inhibitors of Akt as potential anti-cancer agents.
por: Kayser-Bricker, K, et al.
Publicado: (2009)

MEDI 277-Novel alpha-helix mimetics with increased water solubility
por: Cummings, C, et al.
Publicado: (2008)

MEDI 16-Inhibitors of the FBP-FUSE interaction as potential anticancer agents
por: Wyrembak, P, et al.
Publicado: (2007)

MEDI 77-Small alpha-helix mimetics for the inhibition of the estrogen receptor-coactivator interaction
por: Becerril, J, et al.
Publicado: (2006)

Heparin Mimetics: Their Therapeutic Potential
por: Shifaza Mohamed, et al.
Publicado: (2017-10-01)

alpha-Helix mimetics as inhibitors of protein-protein interactions.
por: Saraogi, I, et al.
Publicado: (2008)

Editorial 28.1
por: Rodrigo Moreno Marques, et al.
Publicado: (2019-04-01)

Applications: Abstracts 281-336
por: Swiss Chemical Society
Publicado: (2005-07-01)

ZNF281/Zfp281 is a target of miR-1 and counteracts muscle differentiation
por: Nicolai, S, et al.
Publicado: (2019)

ZNF281/Zfp281 is a target of miR‐1 and counteracts muscle differentiation
por: Sara Nicolai, et al.
Publicado: (2020-02-01)

The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
por: Dustin Chernick, et al.
Publicado: (2020-09-01)

MEDI 298-Design, synthesis and evaluation of inhibitors for the IL-2/IL-2R alpha interaction
por: Saraogi, I, et al.
Publicado: (2008)

Sugar mimetics: Multicomponent glycosyltransferase inhibitors
por: Lucas, R, et al.
Publicado: (2005)

Future Therapeutic Directions for Smac-Mimetics
por: Emma Morrish, et al.
Publicado: (2020-02-01)

COMPARISON BETWEEN ISO 281:1990 AND ISO 281:2007 CALCULATION METHOD FOR ROLLING BEARING LIFE
por: JIANG YuXiao, et al.
Publicado: (2015-01-01)

Identification of natural phytochemicals as AKT2 inhibitors using molecular docking and dynamics simulations as potential cancer therapeutics
por: Jibon Kumar Paul, et al.
Publicado: (2025-01-01)

ZAT 281/4 - Pengantar Mikropemproses
por: PPSF, Pusat Pengajian Sains Fizik
Publicado: (2003)

Pré-textuais / Sumário 28.1
por: Yara Elizabeth Alves
Publicado: (2019-04-01)

Contribuíram nesta edição (28.1)
Publicado: (2020-02-01)

Contribuíram nesta edição (28.1)
Publicado: (2020-02-01)

SMAC Mimetics as Therapeutic Agents in HIV Infection
por: Bengisu Molyer, et al.
Publicado: (2021-11-01)

Upregulation of lnc-ZNF281 Inhibits the Progression of Glioma via the AKT/GSK-3β/β-Catenin Signaling Pathway
por: Yu-Qin Deng, et al.
Publicado: (2021-01-01)

Expression of ZNF281 in colorectal cancer correlates with response to radiotherapy and survival
por: Changjiang Qin, et al.
Publicado: (2023-12-01)

Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer
por: Lucero-Acuña A, et al.
Publicado: (2014-12-01)

Angiopoietin-1 Mimetic Nanoparticles for Restoring the Function of Endothelial Cells as Potential Therapeutic for Glaucoma
por: Raphael Mietzner, et al.
Publicado: (2021-12-01)

Organophosphorus S-adenosyl-L-methionine mimetics: synthesis, stability, and substrate properties
por: Alexander Yu Rudenko, et al.
Publicado: (2024-08-01)

MediJokes
Publicado: (2006-01-01)

Analisis Yuridis Perbandingan Risiko Medis dengan Kelalaian Medis
por: Abdul Kolib
Publicado: (2020-07-01)

Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition
por: Jianguo Zhuang, et al.
Publicado: (2010-01-01)

Potential of Peptides as Inhibitors and Mimotopes: Selection of Carbohydrate-Mimetic Peptides from Phage Display Libraries
por: Teruhiko Matsubara
Publicado: (2012-01-01)

Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential
por: Alexander Fuerlinger, et al.
Publicado: (2025-01-01)

Heparanase in cancer progression: Structure, substrate recognition and therapeutic potential
por: Fengyan Yuan, et al.
Publicado: (2022-09-01)

Nonconventional amide bond formation catalysis: programming enzyme specificity with substrate mimetics
por: F. Bordusa
Publicado: (2000-05-01)

RESIKO MEDIS DAN KELALAIAN MEDIS DALAM ASPEK PERTANGGUNGJAWABAN PIDANA
por: Wahyu Rizki Kartika Ilahi
Publicado: (2018-04-01)

15.281 Advanced Managerial Communication, Spring 2009
por: Hartman, Neal
Publicado: (2009)

15.281 Advanced Managerial Communication, Spring 2004
por: Hartman, Neal
Publicado: (2010)

ZAT 281/4 - PENGANTAR MIKROPEMPROSES FEB 04.
por: PPSF, Pusat Pengajian Sains Fizik
Publicado: (2004)

ZAT 281/4 - PENGANTAR MIKROPEMPROSES APR 2003.
por: PPSF, Pusat Pengajian Sains Fizik
Publicado: (2003)

ZAT 281/4 - PENGANTAR MIKROPEMPROSES FEB 03.
por: PPSF, Pusat Pengajian Sains Fizik
Publicado: (2003)

ZAT 281-3 - INTRODUCTION TO MICROPROCESSORS APRIL 08.
por: PPSF, Pusat Pengajian Sains Fizik
Publicado: (2008)